Company attributes
B2X
CEO
Founder
Pitchbook URL
Legal Name
iGenomX International Genomics Corporation
Date Incorporated
December 24, 2012
Number of Employees (Ranges)
11 – 50
Full Address
5858 Dryden Place Suite 204 Carlsbad, CA 92008 United States
Total Funding Amount (USD)
5,130,000
Latest Funding Round Date
April 2019
Latest Funding Type
Patents Assigned (Count)
2
Country
Other attributes
Company Operating Status
Active
iGenomX developed multiplex genetic sequencing tools with a proprietary technology called RIPTIDE that is used for high0through put mass-scale population genetic sequencing efforts. The tools have applications in various industries including human genomics, agriculture, food safety, microbiome, and synthetic biology.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.